semaglutide pancreatitis Acute due to different regimens: An updated meta-analysis Does Semaglutide Cause Pancreatitis? Evidence

Tirzepatide has a similar action to the semaglutide in Wegovy

Semaglutide is a glucagon-like peptide (GLP-1) receptor agonist that supports healthy blood sugar levels

This is why sometimes, once a type of medication is approved and available, its company may not extend a medication's licence to cover alternative uses (even if it's found to treat or prevent other medical conditions)

Retatrutide is an investigational triple hormone receptor agonist that activates: GLP-1 receptors GIP receptors Glucagon receptors Researchers are studying Retatrutide because these pathways may influence: Appetite regulation Energy balance Body weight Blood sugar control Metabolism Unlike many existing GLP-1 medications, Retatrutide targets three different receptors simultaneously

From there it binds receptors in the pancreas, brain and gut

Dekkers, J